AbbVie
ABBV
#25
Rank
A$594.01 B
Marketcap
$336.48
Share price
-0.24%
Change (1 day)
23.99%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - P/B ratio

P/B ratio as of March 2025 : 111

According to AbbVie's latest financial reports the company has a price-to-book ratio of 6.62939.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AbbVie - P/B ratio (from 2012 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3193.5255.34%
2023-12-3126.359.17%
2022-12-3116.56.61%
2021-12-3115.57.36%
2020-12-3114.4-190.14%
2019-12-31-16.0-0.73%
2018-12-31-16.1-153.29%
2017-12-3130.337.99%
2016-12-3122.0-9.2%
2015-12-3124.2-59.56%
2014-12-3159.8220.35%
2013-12-3118.716.28%
2012-12-3116.0
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.64-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA
7.46-93.28%๐Ÿ‡บ๐Ÿ‡ธ USA
50.5-54.56%๐Ÿ‡บ๐Ÿ‡ธ USA
28.6-74.26%๐Ÿ‡บ๐Ÿ‡ธ USA
7.33-93.39%๐Ÿ‡บ๐Ÿ‡ธ USA
1.23-98.90%๐Ÿ‡บ๐Ÿ‡ธ USA
4.89-95.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.80-94.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.20-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA